ZURA BIO LIMITED (ZURA) ROE
- 2026-06-30: ROE -43.51%.
- 2026-03-31: ROE -34.78%.
- 2025-12-31: ROE -67.61%.
- 2025-09-30: ROE -60.14%.
Complete source-backed roe history.
- Available history
- 2022-06-30 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -43.51% |
| 2026-03-31 | -34.78% |
| 2025-12-31 | -67.61% |
| 2025-09-30 | -60.14% |
| 2025-06-30 | -53.82% |
| 2025-03-31 | -44.93% |
| 2024-12-31 | -35.69% |
| 2024-09-30 | -30.87% |
| 2024-06-30 | -22.25% |
| 2024-03-31 | -95.91% |
| 2023-12-31 | -101.74% |
| 2023-09-30 | -107.23% |
| 2023-06-30 | -87.97% |
| 2023-03-31 | -98.79% |
| 2022-12-31 | 31.59% |
| 2022-09-30 | -162.65% |
| 2022-06-30 | -183.79% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -67.61% |
| 2024-12-31 | -35.69% |
| 2023-12-31 | -101.74% |
| 2022-12-31 | 80.17% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |